TY - JOUR
T1 - Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders
T2 - a meta-analysis
AU - Begemann, Marieke J
AU - Brand, Bodyl A
AU - Ćurčić-Blake, Branislava
AU - Aleman, André
AU - Sommer, Iris E
PY - 2020/11
Y1 - 2020/11
N2 - BackgroundCognition is commonly affected in brain disorders. Non-invasive brain stimulation (NIBS) may have procognitive effects, with high tolerability. This meta-analysis evaluates the efficacy of transcranial magnetic stimulation (TMS) and transcranial Direct Current Stimulation (tDCS) in improving cognition, in schizophrenia, depression, dementia, Parkinson's disease, stroke, traumatic brain injury, and multiple sclerosis.MethodsA PRISMA systematic search was conducted for randomized controlled trials. Hedges' g was used to quantify effect sizes (ES) for changes in cognition after TMS/tDCS v. sham. As different cognitive functions may have unequal susceptibility to TMS/tDCS, we separately evaluated the effects on: attention/vigilance, working memory, executive functioning, processing speed, verbal fluency, verbal learning, and social cognition.ResultsWe included 82 studies (n = 2784). For working memory, both TMS (ES = 0.17, p = 0.015) and tDCS (ES = 0.17, p = 0.021) showed small but significant effects. Age positively moderated the effect of TMS. TDCS was superior to sham for attention/vigilance (ES = 0.20, p = 0.020). These significant effects did not differ across the type of brain disorder. Results were not significant for the other five cognitive domains.ConclusionsOur results revealed that both TMS and tDCS elicit a small trans-diagnostic effect on working memory, tDCS also improved attention/vigilance across diagnoses. Effects on the other domains were not significant. Observed ES were small, yet even slight cognitive improvements may facilitate daily functioning. While NIBS can be a well-tolerated treatment, its effects appear domain specific and should be applied only for realistic indications (i.e. to induce a small improvement in working memory or attention).
AB - BackgroundCognition is commonly affected in brain disorders. Non-invasive brain stimulation (NIBS) may have procognitive effects, with high tolerability. This meta-analysis evaluates the efficacy of transcranial magnetic stimulation (TMS) and transcranial Direct Current Stimulation (tDCS) in improving cognition, in schizophrenia, depression, dementia, Parkinson's disease, stroke, traumatic brain injury, and multiple sclerosis.MethodsA PRISMA systematic search was conducted for randomized controlled trials. Hedges' g was used to quantify effect sizes (ES) for changes in cognition after TMS/tDCS v. sham. As different cognitive functions may have unequal susceptibility to TMS/tDCS, we separately evaluated the effects on: attention/vigilance, working memory, executive functioning, processing speed, verbal fluency, verbal learning, and social cognition.ResultsWe included 82 studies (n = 2784). For working memory, both TMS (ES = 0.17, p = 0.015) and tDCS (ES = 0.17, p = 0.021) showed small but significant effects. Age positively moderated the effect of TMS. TDCS was superior to sham for attention/vigilance (ES = 0.20, p = 0.020). These significant effects did not differ across the type of brain disorder. Results were not significant for the other five cognitive domains.ConclusionsOur results revealed that both TMS and tDCS elicit a small trans-diagnostic effect on working memory, tDCS also improved attention/vigilance across diagnoses. Effects on the other domains were not significant. Observed ES were small, yet even slight cognitive improvements may facilitate daily functioning. While NIBS can be a well-tolerated treatment, its effects appear domain specific and should be applied only for realistic indications (i.e. to induce a small improvement in working memory or attention).
KW - Brain disorder
KW - cognitive dysfunction
KW - non-invasive brain stimulation
KW - prefrontal cortex
KW - repetitive transcranial magnetic stimulation
KW - transcranial direct current stimulation
KW - TRANSCRANIAL MAGNETIC STIMULATION
KW - DORSOLATERAL PREFRONTAL CORTEX
KW - SHAM-CONTROLLED TRIAL
KW - QUALITY-OF-LIFE
KW - PREDOMINANT NEGATIVE SYMPTOMS
KW - ADD-ON TREATMENT
KW - DOUBLE-BLIND
KW - PARKINSONS-DISEASE
KW - WORKING-MEMORY
KW - AUDITORY HALLUCINATIONS
U2 - 10.1017/S0033291720003670
DO - 10.1017/S0033291720003670
M3 - Review article
C2 - 33070785
SN - 0033-2917
VL - 50
SP - 2465
EP - 2486
JO - Psychological Medicine
JF - Psychological Medicine
IS - 15
M1 - 0033291720003670
ER -